PUBLIC VENTURES
Where visionaries come to build a better world.
Climate Change is Personal.
From extreme weather to failing infrastructure, its ripple effects are hitting people first.
At Public Ventures, we invest in bold solutions at the intersection of climate and health. From breakthrough science to real-world deployment, we back visionary entrepreneurs who are tackling the most urgent challenge of our time building a future where resilience is equitable and innovation serves everyone.
Our
Mission
Back Science With A Purpose
We invest in breakthrough technologies rooted in research, intellectual property, and real-world application — not hype. Our focus is on early-stage solutions that can be validated, scaled, and sustained.
Build Systems That Last
We support ventures that strengthen the backbone of society — from healthcare infrastructure to resilient energy systems. Our goal is to fund solutions that integrate into public systems, scale sustainably, and create lasting value for communities.
Scale Resilience
Our portfolio targets the accelerating risks at the intersection of climate and human health: extreme weather, heat, air and water quality, infectious disease, food, allergens, and mental health. We focus on innovations that don’t just respond to crisis, but prepare us for what’s next.
Advance Equity Through Innovation
We prioritize solutions that serve historically overlooked communities. Whether it's health systems in climate-vulnerable regions or clean infrastructure for underserved populations. For us, equity is foundational to how we invest.
Empower Visionaries
We use proprietary tools like the DECA Framework (Deal, Ecosystem, Community, Application) to deploy capital more intelligently and inclusively. Our investment strategy breaks silos, de-risks early-stage innovation, and ensures technologies reach the people and places that need them most.
Our Approach
The climate-related problems we face today demand more than capital.
That’s why we created the DECA Framework — our proprietary approach to identifying, funding, and scaling science-backed solutions with staying power.
-
Structure for Long-Term Success
Using smart, founder-aligned tools like the DECA SAFE, we back startups with strong intellectual property, scientific validation, and a clear path to commercialization.
Our deal structures are built to de-risk innovation, prioritize measurable impact, and position companies for long-term scale.
-
Surround Ventures With Strength
We know that innovation doesn’t grow in isolation; That’s why we partner with leading universities, research labs, hospitals, and test hubs to validate and stress-test technologies in real-world conditions. We connect founders with the institutions, mentors, and systems that can help them grow faster and more sustainably.
-
Invest In People, Not Just Products
The communities most affected by climate and health crises are too often left out of the solution. We invest in ventures that build with those communities — ensuring equitable access, inclusive pricing models, and culturally aligned deployment strategies. Community engagement isn't an afterthought; it's baked into our diligence process.
-
Engineer for Equity
We don’t fund concepts that stay trapped in labs, because impact isn’t just about readiness, it’s about reach.
We focus on ventures whose business models, technologies, and IP can be adapted for use in rural, remote, and undercapitalized regions. If a solution can’t scale to serve the communities most affected by climate and health inequities, it’s not ready.
What We Look For
Market-Ready with Systems Awareness
We look for solutions that fit — or can integrate into — existing systems, whether that's public health infrastructure, regulatory frameworks, or procurement channels. Founders who understand how to navigate institutional pathways are better positioned to scale impact and unlock long-term value.
Capital-Efficient Execution
We partner with founders who use early capital intentionally — with a clear understanding of how to test, validate, and build momentum. Whether it’s proving clinical utility, piloting in a frontline market, or refining a go-to-market strategy, we back teams who make every dollar count.
